Research Interests

The research program in our group integrates organic chemistry, chemical biology, medicinal chemistry and materials chemistry. A special emphasis is placed on training and research in carbohydrate synthesis and on the utilization of this expertise in addressing problems of medicinal and biochemical significance.

·                     Carbohydrate chemistry

·                     Glycopeptide and glycoprotein synthesis

·                     Glycobiology

·                     Antimicrobial Research

·                     Synthetic methods and natural products

·                     Functional materials

 

Positions Available

Research Fellow positions (NEW)

Interested candidates should send a summary of research experience, resume and names of three references to Prof LIU Xuewei (xuewei@ntu.edu.sg) or apply online:

Workday ID: R00004261

https://ntu.wd3.myworkdayjobs.com/Careers/job/NTU-Main-Campus-Singapore/Research-Fellow--Synthetic-Chemists-_R00004261-1

MCF ID: MCF-2020-0311860

https://www.mycareersfuture.gov.sg/job/sciences/research-fellow-nanyang-technological-university-6c77c29b36a27d7e48ef5d193b8dfcbb

Workday ID: R00004262

 

PhD Scholarships in organic chemistry, medicinal chemistry, carbohydrate synthesis, peptide/protein synthesis and glycobiology

Self-motivated individuals are welcome to join us to work in the area of carbohydrate synthesis, glycoprotein synthesis, natural product synthesis, and glycobiology. Interested candidates should contact Prof LIU Xuewei (xuewei@ntu.edu.sg).

 

Selected projects

1)  Carbohydrate Chemistry

a)  Acceptor-controlled Glycosylation and Carbohydrate Synthesis

Notably, we have developed the acceptor-controlled glycosylation methods. We have demonstrated the difference in reactivity of glycosyl acceptors can be employed to completely drive the stereoselectivity, drawing the parallel comparison with the commonly practiced donor-controlled glycosylation. This new concept and method can be applied to efficiently construct different types of glycosidic bonds, which will certainly contribute to the synthesis of oligosaccharides and glycoconjugates significantly. Our contribution was summarized in review papers and book chapters, such as: Acc. Chem. Res. 2018, 51, 628-639; Nat. Commun. 2014, 5, 5051; Angew. Chem. Int. Ed., 2015, 54, 604-607; etc.

i)  Hydrogen-bonding mediated glycosylation

Figure 1: Dual-directing effect of 2-cyano benzyl ether group on stereospecific glycosylation

ii)  Palladium mediated glycosylation

Figure 2: Reversing stereoselectivity via inner sphere or outer sphere pathway

b)  Protection-less/free Glycosylation and Efficient Carbohydrate Synthesis

Orthogonal protections and selective deprotection are considered critical for regio- and stereocontrol in chemical synthesis of complex and diverse oligosaccharides. The boron-mediated protection-less/free glycosylation we have developed significantly shortens the synthetic plan, and laborious orthogonal protection/deprotection steps could be avoided/minimized. With great advantages and flexibility (Figure 3), our synthetic protocols can be more elegantly streamlined for both linear oligosaccharides and branching N-glycans. Some results have been published, such as: Nat. Commun.  2017, 8, 1146; etc.

Figure 3: Boron-mediated glycosylation and efficient carbohydrate synthesis

2)  Dual Native Chemical Ligation (dNCL) and Complex Protein Synthesis

We have developed conceptually new dual Native Chemical Ligation (dNCL) methods that enable quick assembly of tagged peptides and post-translationally modified proteins.

i)   Asp-based dual native chemical ligation and glycoprotein synthesis

We have developed a practical approach towards N-glycopeptide and N-glycoprotein synthesis using an auxiliary-mediated dual native chemical ligation (dNCL), as shown in Figure 4. Results were published: Angew. Chem. Int. Ed., 2016, 55, 10363-10367. Highlighted by X-MOL.

Figure 4: Quick assembly of homogeneous glycoproteins and glycopeptides via dNCL

ii)  Lys-based dual native chemical ligation and di-ubiquitin synthesis

In collaboration with Prof Liu Chuanfa’s group, we have designed and prepared the 4-mercaptolysine that can mediate dual chemical ligation at both α- and ε- amines of lysine via favourable 6-membered ring transition state (Figure 5). It has become a general strategy and practical method to form branched peptides tagged peptides. Results were published: 1) Bioorg. Med. Chem. Lett., 2009, 19, 6268-6271; 2) J. Am. Chem. Soc., 2009, 131, 13592-13593. This work was highlighted twice by Chemical & Engineering News (C&EN, Sept. 21, 2009; and Nov. 16, 2009). This method was applied to the synthesis of K48-linked di-ubiquitin (Figure 5). Results were published: Chem. Commun., 2010, 46, 7199-7201. This work was highlighted by Chemical & Engineering News (C&EN, Oct. 11, 2010, PP36-37). It was also selected for Chemical Year in Review (C&EN, Dec. 20, 2010, PP13-17) (Figure 6).

Figure 5: Quick assembly of branching peptides and di-ubiquitin via Lys-based dNCL

Graphical user interface, application

Description automatically generated with medium confidence

Figure 6: Our Lys-based dNCL highlighted by Chemical & Engineering News.

3)  Antimicrobial Program: Strategic Synthesis of Peptidoglycans

Peptidoglycans are unique structures that are present in all bacterial cell wall, making them an attractive target for development of wide-spectrum antibiotics. We developed the first top-down approach to synthesize biohybrid peptidoglycan oligomers (PGOs) in a highly practical and efficient manner, starting with the plentiful shrimp shell-derived biopolymer chitosan. We confirmed the incorporation of PGO into the cell walls of multiple strains of wild-type bacteria. We have demonstrated that PGOs can be a powerful tool to study bacterial cell wall biogenesis and antimicrobial therapeutics. Results were published: Chem. Sci., 2020, 11, 3171-3179.

Figure 7: Re-tailoring chitosan as new transglycosylase substrates for mechanistic studies

4)  Sugar-oriented Synthesis of Natural Products and Drugs

The sweet use of sugars in organic synthesis often provides unexpected conciseness and new possibilities. We are strongly interested in economic synthesis of biologically unique natural products and drugs, starting from sugars. Many results have been published in top journals: 1) Angew. Chem. Int. Ed., 2011, 50, 12054-12057; 2) Angew. Chem. Int. Ed., 2013, 52, 5134-5137; Highlight in SYNFACTS 2013, 9, 870; 3) Chem. Eur. J., 2014, 20, 405-409; 4) Angew. Chem. Int. Ed., 2014, 53, 10742-10746; 5) Chem. Sci. 2017, 8, 6656-6661; etc.

Figure 8: Concise synthesis of natural products and drugs starting from D-glucal

5)  Chemical Glycobiology: Exploring and Exploiting Carbohydrate-Lectin Interactions

Carbohydrate-lectin interactions are fundamentally important in various biological processes and play key roles in cancers, immune diseases, infectious diseases, etc. We are exploring and exploiting carbohydrate-lectin interactions at the cell surface, by creating new interdisciplinary approaches and possibilities within chemistry. For example:

i)    “Turn off/turn on” biosensor

We have developed a novel “turn-off/turn-on” biosensor system to quantify any specific carbohydrate-lectin interactions (Figure 9). Results were published: 1) J. Am. Chem. Soc., 2012, 134, 15229-15232; 2) Chem. Sci., 2017, 8, 3980-3988; etc.

Figure 9: “Turn-off” and “turn-on” system to probe carbohydrate-lectin interactions

ii)     Cell secretion biosensor

Figure 10: Glycosylated nanotubes interfacing living cells to detect neuron cell secretion

We have developed the cell secretion biosensor (Figure 10). Comparing to current methods to detect exocytosis, our approach provides real-time and non-invasive measurements from living cells with high sensitivity, high temporal resolution, high throughput and ease of use. The study represents a great example of how carbohydrates and nanomaterials can bring new opportunities to biology. Potentially, it can be applied to screen the side effects of drugs and drug candidates on central nervous system in developing new drugs. Results were published: 1) Angew. Chem. Int. Ed., 2009, 48, 2723-2726; 2) Chem. Eur. J., 2010, 16, 4533-4540; 3) Chem. Soc. Rev., 2010, 39, 2925-2934; etc.